Generic drugs

2 US Sun Pharma units to pay $ 85 million in MDL generic drugs

By Hailey Konnath (Nov 5, 2021, 10:04 p.m. EDT) – Two U.S. subsidiaries of Indian drugmaker Sun Pharma have agreed to pay a combined $ 85 million to a proposed class of direct buyer applicants under a large multidistrict dispute over the alleged price. fixing of generic drugs, the companies reportedly disclosed.

Taro Pharmaceuticals USA Inc. will pay $ 67.6 million to settle the antitrust dispute in Pennsylvania federal court, the company revealed Thursday in a filing with the United States Securities and Exchange Commission.

Taro has entered into an agreement with César Castillo LLC, FWK Holdings LLC, Rochester Drug Cooperative Inc. and KPH Healthcare Services Inc. on behalf of the putative class of all …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific case articles and topics and more!


Tags : generic drugsunited states
Joan J. Dean

The author Joan J. Dean